Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,354 public trials 2,837 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

NCT06051409

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Ascentage Investigative Site #1044 Birmingham, Alabama, United States

Ascentage Investigative Site #1062 Duarte, California, United States

Ascentage Investigative Site #1134 Los Angeles, California, United States

Ascentage Investigative Site #1059 Los Angeles, California, United States

View all 90 locations

View Trial Details

Recruiting

CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia

NCT06696846

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes

NCT03058588

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations: Chair of Hematology and Bone marrow Transplant Unit Brescia, Italy

View Trial Details

Recruiting

High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia

NCT07559331

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Qilu Hospital of Shandong University Jinan, Shandong, China

View Trial Details

Recruiting

A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall Sur-vival in Patients With Chronic Lymphocytic Leukaemia (CLL) Treated Within First-line Studies of the GCLLSG

NCT06792994

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: University Hospital Cologne Cologne, Germany

Universitätsklinikum Ulm Ulm, Germany

View Trial Details

Recruiting

Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial

NCT07420790

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: USD TMO Adulti Brescia, Italy

View Trial Details

Recruiting

the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

NCT07380646

Conditions: Agranulocytosis, Breast Cancer, Breast Diseases, +14 more
Locations: Breast surgery department Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

NCT05536349

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie"

NCT04888039

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: IUCT-Oncopole - Toulouse University Hospital Toulouse, West-Occitanie, France

View Trial Details

Recruiting

A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma

NCT07075328

Conditions: Adult T-Cell Leukemia/Lymphoma (ATLL), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: National Kyushu Cancer Center Fukuoka, Japan

Sapporo Hokuyu Hospital Sapporo, Hokkaido, Japan

Imamura general hospital Kagoshima, Kagoshima-ken, Japan

University of Miyazaki Hospital Miyazaki, Japan

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions